End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,690 KRW | 0.00% | +0.15% | -4.84% |
2023 | Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Animal Medicine
54.2
%
| 9,185 | 57.4 % | 9,411 | 54.2 % | +2.47% |
Animal Disease Diagnosis
25.4
%
| 3,753 | 23.4 % | 4,404 | 25.4 % | +17.37% |
Bacteriophage
10.9
%
| 1,735 | 10.8 % | 1,900 | 10.9 % | +9.52% |
Medipig
8.5
%
| 1,276 | 8.0 % | 1,470 | 8.5 % | +15.24% |
Others
1.1
%
| 60 | 0.4 % | 187 | 1.1 % | +210.00% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 16,008 | 100.0 % | 17,373 | 100.0 % | +8.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 52 | - |
Ki-Myung Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Beom-Gu Han
BRD | Director/Board Member | 55 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 52 | - |
Ki-Myung Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Young-Ho Kim
BRD | Director/Board Member | 47 | - |
Jae-Wan Park
BRD | Director/Board Member | 44 | - |
Hyeon-Wuk Choi
BRD | Director/Board Member | 49 | - |
Beom-Gu Han
BRD | Director/Board Member | 55 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,669,958 | 8,652,777 ( 58.98 %) | 0 | 58.98 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-4.84% | 72.33M | |
-9.26% | 6.54B | |
+27.25% | 3.8B | |
-3.06% | 3.2B | |
+11.32% | 1.5B | |
-14.30% | 1.44B | |
-23.61% | 1.28B | |
-9.13% | 1.21B | |
-6.93% | 1.2B | |
+3.84% | 1.06B |
- Stock Market
- Equities
- A153710 Stock
- Company Optipharm.CO.,LTD